Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems
ACS Nano · 2024
DOI: 10.1021/acsnano.3c10133 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Nian Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China. Hauptthemen laut MEDLINE: Ferroptosis, Prodrugs, Organophosphorus Compounds. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis is a form of regulated cell death accompanied by lipid reactive oxygen species (ROS) accumulation in an iron-dependent manner. However, the efficiency of tumorous ferroptosis was seriously restricted by intracellular ferroptosis defense systems, the glutathione peroxidase 4 (GPX4) system, and the ubiquinol (CoQH2) system. Inspired by the crucial role of mitochondria in the ferroptosis process, we reported a prodrug nanoassembly capable of unleashing potent mitochondrial lipid peroxidation and ferroptotic cell death. Dihydroorotate dehydrogenase (DHODH) inhibitor (QA) was combined with triphenylphosphonium moiety through a disulfide-containing linker to engineer well-defined nanoassemblies (QSSP) within a single-molecular framework. After being trapped in cancer cells, the acidic condition provoked the structural disassembly of QSSP to liberate free prodrug molecules. The mitochondrial membrane-potential-driven accumulation of the lipophilic cation prodrug was delivered explicitly into the mitochondria. Afterward, the thiol-disulfide exchange would occur accompanied by downregulation of reduced glutathione levels, thus resulting in mitochondria-localized GPX4 inactivation for ferroptosis. Simultaneously, the released QA from the hydrolysis reaction of the adjacent ester bond could further devastate mitochondrial defense and evoke robust ferroptosis via the DHODH-CoQH2 system. This subcellular targeted nanoassembly provides a reference for designing ferroptosis-based strategy for efficient cancer therapy through interfering antiferroptosis systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.
- School of Medicine, Xiamen University, Xiamen 361102, China.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
- Xiamen University
Zitieren
APA
Liu, N., Lin, Q., Huang, Z., Liu, C., Qin, J., Yu, Y., Chen, W., Zhang, J., Jiang, M., Gao, X., Huo, S., & Zhu, X. (2024). Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems. ACS Nano. https://doi.org/10.1021/acsnano.3c10133
Vancouver
Liu N, Lin Q, Huang Z, Liu C, Qin J, Yu Y, et al. Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems. ACS Nano. 2024. doi:10.1021/acsnano.3c10133
BibTeX
@article{Liu2024,
author = {Liu, Nian and Lin, Qian and Huang, Zhenkun and Liu, Chen and Qin, Jingbo and Yu, Yanlin and Chen, Weibin and Zhang, Jingbo and Jiang, Min and Gao, Xuemin and Huo, Shuaidong and Zhu, Xuan},
title = {Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.3c10133}
}
EUVIMED